Article
Regulatory approved monoclonal antibodies contain framework mutations predicted from human antibody repertoires
2021-06-22
Abstract excerpt
Monoclonal antibodies (mAbs) are an important class of therapeutics used to treat cancer, inflammation, and infectious diseases. Identifying highly developable mAb sequences in silico could greatly reduce the time and cost required for therapeutic mAb development. Here, we present position-specific scoring matrices (PSSMs) for antibody framework mutations developed using natural human antibody repertoire sequence...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b874321b-01dc-5872-ad41-7c7ded5506e7
- DOI
- 10.1101/2021.06.22.449488
